{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT00546143",
      "orgStudyIdInfo": {
        "id": "CIGE025A2208"
      },
      "organization": {
        "fullName": "Novartis",
        "class": "INDUSTRY"
      },
      "briefTitle": "Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma",
      "officialTitle": "Multi-center, Open-label, Multiple Dose Study in Mild to Moderate Asthmatics (With IgE/Body Weight Combinations Above That in the SmPC Dosing Table) to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Omalizumab"
    },
    "statusModule": {
      "statusVerifiedDate": "2010-09",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2007-07"
      },
      "primaryCompletionDateStruct": {
        "date": "2008-08",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2007-10-17",
      "studyFirstSubmitQcDate": "2007-10-17",
      "studyFirstPostDateStruct": {
        "date": "2007-10-18",
        "type": "ESTIMATED"
      },
      "lastUpdateSubmitDate": "2010-09-01",
      "lastUpdatePostDateStruct": {
        "date": "2010-09-02",
        "type": "ESTIMATED"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "oldNameTitle": "External Affairs",
        "oldOrganization": "Novartis"
      },
      "leadSponsor": {
        "name": "Novartis",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false
    },
    "descriptionModule": {
      "briefSummary": "This study will evaluate the safety and efficacy of omalizumab against asthma attacks in mild to moderate allergic asthma"
    },
    "conditionsModule": {
      "conditions": [
        "Asthma"
      ],
      "keywords": [
        "Asthma, anti-immunoglobulin E, omalizumab"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "designInfo": {
        "allocation": "NON_RANDOMIZED",
        "interventionModel": "PARALLEL",
        "primaryPurpose": "TREATMENT",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 32,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "1",
          "type": "EXPERIMENTAL",
          "description": "Omalizumab 900 mg",
          "interventionNames": [
            "Drug: Omalizumab"
          ]
        },
        {
          "label": "2",
          "type": "EXPERIMENTAL",
          "description": "Omalizumab 1050 mg",
          "interventionNames": [
            "Drug: Omalizumab"
          ]
        },
        {
          "label": "3",
          "type": "EXPERIMENTAL",
          "description": "Omalizumab 1200 mg",
          "interventionNames": [
            "Drug: Omalizumab"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DRUG",
          "name": "Omalizumab",
          "armGroupLabels": [
            "1"
          ],
          "otherNames": [
            "Xolair, IGE025"
          ]
        },
        {
          "type": "DRUG",
          "name": "Omalizumab",
          "armGroupLabels": [
            "2"
          ],
          "otherNames": [
            "Xolair, IGE025"
          ]
        },
        {
          "type": "DRUG",
          "name": "Omalizumab",
          "armGroupLabels": [
            "3"
          ],
          "otherNames": [
            "Xolair, IGE025"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Safety and tolerability of omalizumab assessed by AEs and SAEs"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "- Pharmacokinetic/pharmacodynamic profile of multiple administrations of omalizumab to patients with mild to moderate allergic asthma - Pre-dose specific IgE levels"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of allergic asthma \\>= 1 year duration and a history consistent with Step 2 or 3 clinical features from the Global Initiative for Asthma guidelines.\n* Eligible baseline serum immunoglobulin E (IgE) levels value and body-weight combinations\n\nExclusion Criteria:\n\n* Documented medical history of anaphylaxis\n* Lung disease other than mild to moderate allergic asthma such as chronic obstructive pulmonary disease (COPD)\n\nOther protocol-defined inclusion/exclusion criteria may apply.",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "maximumAge": "55 Years",
      "stdAges": [
        "ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Novartis",
          "affiliation": "Novartis investigative site",
          "role": "PRINCIPAL_INVESTIGATOR"
        }
      ],
      "locations": [
        {
          "facility": "Novartis Investigative Site",
          "city": "Berlin",
          "country": "Germany",
          "geoPoint": {
            "lat": 52.52437,
            "lon": 13.41053
          }
        },
        {
          "facility": "Novartis Investigative site",
          "city": "Hamburg",
          "country": "Germany",
          "geoPoint": {
            "lat": 53.55073,
            "lon": 9.99302
          }
        },
        {
          "facility": "Novartis investigative site",
          "city": "Hanover",
          "country": "Germany",
          "geoPoint": {
            "lat": 52.37052,
            "lon": 9.73322
          }
        },
        {
          "facility": "Novartis investigative site",
          "city": "Mainz",
          "country": "Germany",
          "geoPoint": {
            "lat": 49.98185,
            "lon": 8.28008
          }
        },
        {
          "facility": "Novartis Investigative site",
          "city": "Bloemfontein",
          "country": "South Africa",
          "geoPoint": {
            "lat": -29.12107,
            "lon": 26.214
          }
        }
      ]
    },
    "referencesModule": {
      "references": [
        {
          "pmid": "24657236",
          "type": "DERIVED",
          "citation": "Kornmann O, Watz H, Fuhr R, Krug N, Erpenbeck VJ, Kaiser G. Omalizumab in patients with allergic (IgE-mediated) asthma and IgE/bodyweight combinations above those in the initially approved dosing table. Pulm Pharmacol Ther. 2014 Aug;28(2):149-53. doi: 10.1016/j.pupt.2014.03.003. Epub 2014 Mar 18."
        }
      ]
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04"
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D001249",
          "term": "Asthma"
        }
      ],
      "ancestors": [
        {
          "id": "D001982",
          "term": "Bronchial Diseases"
        },
        {
          "id": "D012140",
          "term": "Respiratory Tract Diseases"
        },
        {
          "id": "D008173",
          "term": "Lung Diseases, Obstructive"
        },
        {
          "id": "D008171",
          "term": "Lung Diseases"
        },
        {
          "id": "D012130",
          "term": "Respiratory Hypersensitivity"
        },
        {
          "id": "D006969",
          "term": "Hypersensitivity, Immediate"
        },
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        },
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    },
    "interventionBrowseModule": {
      "meshes": [
        {
          "id": "D000069444",
          "term": "Omalizumab"
        }
      ],
      "ancestors": [
        {
          "id": "D000888",
          "term": "Antibodies, Anti-Idiotypic"
        },
        {
          "id": "D000906",
          "term": "Antibodies"
        },
        {
          "id": "D007136",
          "term": "Immunoglobulins"
        },
        {
          "id": "D007162",
          "term": "Immunoproteins"
        },
        {
          "id": "D001798",
          "term": "Blood Proteins"
        },
        {
          "id": "D011506",
          "term": "Proteins"
        },
        {
          "id": "D000602",
          "term": "Amino Acids, Peptides, and Proteins"
        },
        {
          "id": "D061067",
          "term": "Antibodies, Monoclonal, Humanized"
        },
        {
          "id": "D000911",
          "term": "Antibodies, Monoclonal"
        },
        {
          "id": "D012712",
          "term": "Serum Globulins"
        },
        {
          "id": "D005916",
          "term": "Globulins"
        }
      ]
    }
  },
  "hasResults": false
}